Mr. David Moloney:

Quite a number of spending reviews related to health have been done over time. Initially, they were mostly done by the Department of Public Expenditure and Reform. More recently, they have been done in collaboration between the Department of Public Expenditure and Reform and the Department of Health, or by the Department of Health itself. Some of the significant issues that were covered and informed policy in the area included work on the nursing homes support scheme, which is called the fair deal scheme. That has fed into the review of costings for that scheme. We have negotiated agreements on pharmaceutical pricing. IGEES did work which the Department greatly informed. As I said to Deputy Verona Murphy, IGEES has been around for ten years. The Government Economic Service, GES, in the UK has been around for 50 years. It is in a phase where collecting data and using those data to inform policy is at its core. Over time, it will become even more impactful.